222
Views
0
CrossRef citations to date
0
Altmetric
Letter to the Editor: Original Scientific Contribution

Plasma concentrations of phenibut and mitragynine in a single patient

ORCID Icon, ORCID Icon, &
Pages 561-562 | Received 07 Apr 2023, Accepted 18 Jun 2023, Published online: 07 Jul 2023

References

  • Owen DR, Wood DM, Archer JR, et al. Phenibut (4-amino-3-phenyl-butyric acid): availability, prevalence of use, desired effects and acute toxicity. Drug Alcohol Rev. 2016;35(5):591–596. doi: 10.1111/dar.12356.
  • Todd DA, Kellogg JJ, Wallace ED, et al. Chemical composition and biological effects of kratom (mitragyna speciosa): in vitro studies with implications for efficacy and drug interactions. Sci Rep. 2020;10(1):19158. doi: 10.1038/s41598-020-76119-w.
  • Trakulsrichai S, Sathirakul K, Auparakkitanon S, et al. Pharmacokinetics of mitragynine in man. Drug Des Devel Ther. 2015;9:2421–2429.
  • Tanna RS, Nguyen JT, Hadi DL, et al. Clinical pharmacokinetic assessment of kratom (mitragyna speciosa), a botanical product with opioid-like effects, in healthy adult participants. Pharmaceutics. 2022;14(3):620. doi: 10.3390/pharmaceutics14030620.
  • Lapin I. Phenibut (beta-phenyl-GABA): a tranquilizer and nootropic drug. CNS Drug Rev. 2001;7(4):471–481. doi: 10.1111/j.1527-3458.2001.tb00211.x.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.